AzTrials
AzTrials

Postoperative Nausea and VomitingNCT02355678

Dexamethasone Versus Local Infiltration Technique for Tonsillectomy in Children

A study testing dexamethasone, Local anesthetic infiltration and General anesthesia in people with Postoperative Nausea and Vomiting, run by Makassed General Hospital at 1 site in Lebanon.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Tonsillectomy is one of the most frequent surgical operations performed in children [1-4]. It is usually associated with postoperative nausea and vomiting (PONV) with an incidence ranging from 23% to 73% [2]. Read more about this study

Who is it for?
Ages 2 to 13 yearsHealthy volunteers can take part
Conditions the study is for
Postoperative Nausea and Vomiting
What is being tested?
dexamethasone, Local anesthetic infiltration and General anesthesia
Could I receive a placebo?
No, everyone receives an active treatment
How many people
129 participants
Where
1 siteLebanon
Study dates
Jan 2015to Aug 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 13 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Patients scheduled for total or partial tonsillectomy with or without adenoidectomy

Who cannot join

  • Patients who received antiemetics, steroids, antihistaminics, or psychoactive drugs within 24 hours before surgery.
  • Patients who are suspected to have malignant neoplasm and signs of acute pharyngeal infection..
  • Patients who have asthma, diabetes mellitus, bleeding problems, and allergy towards bupivacaine.

Trial locations and contacts

1 site in 1 country.

Lebanon1 site
  • Makassed General Hospital

    Beirut

Other trials in Lebanon

About this study

Official title: The Effect of Dexamethasone Versus Local Infiltration Technique on Postoperative Nausea and Vomiting After Tonsillectomy in Children: A Randomized Double-blind Clinical Trial

Tonsillectomy is one of the most frequent surgical operations performed in children [1-4]. It is usually associated with postoperative nausea and vomiting (PONV) with an incidence ranging from 23% to 73% [2]. Dexamethasone has been shown to be effective in reducing PONV after tonsillectomy using standardized anesthetic technique [2, 5-7]. Previous studies utilizing a different technique, the pre-incision infiltration of local anesthesia, had shown to decrease post-tonsillectomy pain, reduce analgesic consumption and provide a rapid return to normal activity [8, 9]. Given the effectiveness of dexamethasone and the pre-incision infiltration anesthetic technique, it would be beneficial to compare the effect of each on PONV.

Read the detailed description

Objective The purpose of this study is to compare the effect of dexamethasone versus the pre-incision infiltration of local anesthesia in pediatric tonsillectomy procedures. The primary outcome parameter of the study is the incidence of early PONV in the post-anesthesia care unit (PACU) and late PONV on the floor and 5 days after discharge. The secondary outcome is postoperative pain.

Methods Definitions Nausea is difficult to assess in children since they are not able to verbalize their feelings. Retching, which is the unproductive effort to vomit (no expulsion of gastric content), is considered an indicator of nausea. Therefore, for the purpose of this study, PONV is defined as vomiting and/or retching. Early PONV is defined as vomiting and/or retching in the PACU. Late PONV is defined as vomiting and/or retching on the floor and 5 days after discharge.

Study design The study will be conducted prospectively, using a randomized double-blinded placebo-controlled design. Thus, neither the surgeon nor the anesthesiologist will be aware of the injected solution content and they will not be involved in data collection. The patients and the residents who will collect the data will also be unaware of the patient's assigned group.

Sampling

Patients scheduled for total or partial tonsillectomy with or without adenoidectomy starting from January 2015, whose ages range between 2 to 13 years will be included in the study.

Exclusion criteria consisted of patients who received antiemetics, steroids, antihistaminics, or psychoactive drugs within 24 hours before surgery. Patients who are suspected to have malignant neoplasm and signs of acute pharyngeal infection will be excluded from the study. Moreover, patients who have asthma, diabetes mellitus, bleeding problems, and allergy towards bupivacaine are excluded as well.

Upon meeting the eligibility criteria and signing the consent form, patients will be allocated randomly into two equal groups using the sealed envelope method. Both groups will have general anesthesia (GA) and endotracheal intubation. Then, one group will receive dexamethasone 0.5 mg/kg IV with placebo pre-incision infiltration. The other group will receive pre-incision infiltration of 1.5 ml local anesthesia mixture in each tonsil and an equivalent volume of IV saline.

Anesthetic techniques General anesthesia General anesthesia will be induced by intravenous fentanyl (1.5 µg kg-1) and propofol (2.5 mg kg-1) followed by endotracheal intubation facilitated by atracurium (0.5 mg kg-1). Anesthesia will be subsequently maintained with sevoflurane 1-3%, fentanyl (1-2 µg kg-1), nitrous oxide 70% and oxygen 30%. The sevoflurane concentration will be adjusted with the intention of keeping the heart rate and blood pressure within 25% of pre-induction values [8, 9].

Modified infiltration technique The infiltration will be performed by the anesthetist using a 25G- 3.5cm curved needle. A total of 1.5 ml of local anesthetic mixture will be used for each tonsil. The mixture will contain: 3 ml lidocaine 2%, 3 ml lidocaine 2% with epinephrine 1/200 000, 3 ml of bupivacaine 0.5%, 0.5 ml fentanyl 50 µg ml-1, and 0.3 ml clonidine 150 µg ml-1 [8, 9].

Surgical techniques The tonsillectomy techniques were monopolar electrocautery or cold dissection. The degree of tonsillar enlargement was graded as follows: tonsils within tonsillar folds; tonsils just outside tonsillar folds; tonsils well outside tonsillar folds but not reaching uvula; tonsils reaching uvula or past uvula [3]. Towards the end of the surgery, gastric contents of all patients will be suctioned via an orogastric tube prior to extubation [10]. Patients were extubated when fully awake. Systemic IV paracetamol (15 mg/kg) was given to all patients.

Data collection Pre- and intraoperative data include: patient's demographics, surgical technique, amount of fentanyl consumed, heart rate, mean arterial pressure and oxygen concentration in addition to surgery duration. Data to be collected postoperatively in the PACU (by PACU nurse) and floor included: frequency of PONV, pain scores, antiemetic and analgesic consumption as well as patients' and surgeons' satisfaction. PONV will be assessed using questions adopted from Rhodes Index of Nausea, Vomiting and Retching (RINVR) but was modified for pediatrics [11, 12]. For children aged five years and older, pain will be measured using the Visual Analog Scale (VAS) with a score of 0 denoting no pain and 10 maximum possible pains. For children less than five years of age, the Wong-Baker faces pain scale will be used. Pain will be assessed at rest in addition to when opening the jaw, swallowing, eating soft and ordinary food. The parents will be told that they will be contacted through phone calls after their hospital discharge on a daily basis and will be asked about the pain intensity and analgesic consumption of their child. Patients will be followed-up by anesthesiology resident for five postoperative days.

Parents' satisfaction will be based on quality of communication and care provided by the anesthesiologists and nurses, in addition to parental opinion of the child's recollection and the overall experience. Surgeon satisfaction will be assessed using patients' comfort and number of phone calls made by parents.

Since the study is double-blind, neither the surgeon nor the anesthesiologist are aware of the injected solution content and were not involved in data collection. The patients and the trained nurses who collect the data are also unaware of the patient's assigned group.

Postoperative pain management For pain scores >5, 1-2 mg/kg of tramadol hydrochloride (Tramal drops, Laboratoire, Grunenthal, Aachen-Germany) would be given. If pain score is between 4 and 5, 15mg/kg intravenous propacetamol hydrochloride (Pro-Dafalgan Laboratoires, UPSA, Agen, France) will be provided. Paracetamol suppository 350 mg (Tylenol CILAG SA, Schaffhouse, Switzerland) will be administered for children with pain scores <4. Paracetamol suppository 350 mg is prescribed systematically two to four times a day as needed to all discharged children. If they experience pain with a score >5, tramadol hydrochloride will be prescribed.

Statistical Analysis Data will be statistically analyzed by chi-square test and t-test (two-tailed). P-value < 0.05 is considered significant. Results will be reported as mean and standard deviation (SD), or frequency and percentage as appropriate.

Being tested
dexamethasone, Local anesthetic infiltration, General anesthesia, Tonsillectomy, gastric content suction
Medical subject headings
Postoperative Nausea and Vomiting

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • dexamethasoneDrug

    IV 0.5 mg/kg

  • Local anesthetic infiltrationDrug

    Using 25 G-3.5 cm curved needle

  • General anesthesiaDrug

    Induction by intravenous fentanyl (1.5 µg kg-1) and propofol (2.5 mg kg-1) followed by endotracheal intubation facilitated by atracurium (0.5 mg kg-1).

    Maintenance with sevoflurane 1-3%, fentanyl (1-2 µg kg-1), nitrous oxide 70% and oxygen 30%.

  • TonsillectomyProcedure or surgery

    Mono-polar electrocautery or cold dissection

  • gastric content suctionProcedure or surgery

    By orogastric tube

  • Tramadol hydrochlorideDrug

    If Visual Analogue Scale was greater than 5

  • Propacetamol hydrochlorideDrug

    If Visual Analogue Scale was between 4 and 5

  • Paracetamol SuppositoryDrug

    If Visual Analogue Scale was less than 4

Study groups in NCT02355678
Study groupRoleWhat they receive
IV DexExperimentaldexamethasone 0.5 mg/kg IV with placebo pre-incision infiltration
Receives: Drug: dexamethasone; Drug: General anesthesia; Procedure: Tonsillectomy; Procedure: gastric content suction; Drug: Tramadol hydrochloride; Drug: Propacetamol hydrochloride; Drug: Paracetamol Suppository
InfiltrationExperimentalThe infiltration will be performed by the anesthetist using a 25G- 3.5cm curved needle. A total of 1.5 ml of local anesthetic mixture will be used for each tonsil. The mixture will contain: 3 ml lidocaine 2%, 3 ml lidocaine 2% with epinephrine 1/200 000, 3 ml of bupivacaine 0.5%, 0.5 ml fentanyl 50 µg ml-1, and 0.3 ml clonidine 150 µg ml-1
Receives: Drug: Local anesthetic infiltration; Drug: General anesthesia; Procedure: Tonsillectomy; Procedure: gastric content suction; Drug: Tramadol hydrochloride; Drug: Propacetamol hydrochloride; Drug: Paracetamol Suppository

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of postoperative nausea and vomiting

    incidence of early PONV in the post-anesthesia care unit (PACU) and late PONV on the floor and 5 days after discharge

    Measured: 5 postoperative days

Secondary outcomes (1)
  1. Postoperative pain

    Measured: 5 postoperative days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Feb 2015 (estimated)
  2. Study startJan 2015
  3. Primary completionAug 2015
  4. Study completionAug 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Investigator
Enrolment
129 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02355678
Sponsor's protocol ID
201212
Status last verified
Aug 2015
First submitted
26 Jan 2015
Last updated
21 Aug 2015
Results posted
No
Data monitoring committee
No

Publications

  • Naja Z, Kanawati S, Al Khatib R, Ziade F, Naja ZZ, Naja AS, Rajab M. The effect of IV dexamethasone versus local anesthetic infiltration technique in postoperative nausea and vomiting after tonsillectomy in children: A randomized double-blind clinical trial. Int J Pediatr Otorhinolaryngol. 2017 Jan;92:21-26. doi: 10.1016/j.ijporl.2016.10.030. Epub 2016 Oct 28.

    PubMed 28012528

Questions about this trial

What is this clinical trial studying?

A study testing dexamethasone, Local anesthetic infiltration and General anesthesia in people with Postoperative Nausea and Vomiting, run by Makassed General Hospital at 1 site in Lebanon.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Aug 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Lebanon. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of postoperative nausea and vomiting (time frame: 5 postoperative days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02355678, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in